IL2 and cancer: So, an approach that we propose to boost the anticancer response of the immune system is to “tag” cancer cells with specific antibodies, and activate both the antigen presentation and lymphocytes with Th1 cytokines (IFN-α, TNF-α, IL-2, IFN-γ, and IL-12).